ICICI Prudential Pharma Healthcare & Diagnostics IDCW Payout Direct Plan
SIP amount
Min. ₹100
Lumpsum amount
Min. ₹5,000

ICICI Prudential Pharma Healthcare & Diagnostics IDCW Payout Direct Plan

NAV
₹26.0300
-2.00%
(25 Apr)
AUM
4,915 Cr
TER
1.18%
Risk
Very High Risk
Insights
Net Asset Value (NAV) is below its 200 days moving average
In beta. Send feedback here.
Compare with other fund
1Y
+21.6%
+13.0%
+3.9%
+3.9%
+3.9%
3Y
+24.6%
+29.6%
+32.0%
+32.0%
+32.0%
5Y
+23.4%
+33.5%
+33.3%
+33.3%
+33.3%
ALL
+20.7%
+17.9%
+12.1%
+12.1%
+12.1%
VOL
17.0%
18.0%
20.4%
20.4%
20.4%
TER
1.2%
0.6%
0.8%
0.8%
0.8%
AUM
₹4,915 Cr
₹6,047 Cr
₹4,789 Cr
₹4,789 Cr
₹4,789 Cr
INFO
1.22
0.99
0.59
0.59
0.59
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
ICICI Pru Pharma Healthcare & Diagnostics IDCW Payout (DP)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 31st Mar
Top holdings
Sun Pharmaceuticals Industries Ltd
13.5%
Dr Reddy's Laboratories Ltd
8.9%
Cipla Ltd
8.8%
Divi's Laboratories Ltd
6.7%
Aurobindo Pharma Ltd
5.3%
Lupin Ltd
4.7%
Alkem Laboratories Ltd
4.4%
Mankind Pharma Ltd
3.5%
Gland Pharma Ltd
3.4%
Zydus Lifesciences Ltd
3.1%
Top industry exposure
Healthcare
89.4%
Basic Materials
6.0%
Financial Services
2.9%
Other information
Minimum SIP
₹100
Minimum lumpsum
₹5,000
Additional lumpsum
₹1,000
Portfolio turnover
83%
Lock-in period
-
Exit load
• 1% for redemption within 15 days
Fund objective
To generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies. However there can be no assurance or guarantee that the investment objectives of the scheme would be achieved.
Fund manager(s)
Dharmesh Kakkad
Sharmila D’mello

FAQs